Once-daily glatiramer acetate decreases magnetic resonance imaging disease activity in Japanese patients with relapsing-remitting multiple sclerosis.

Clin Exp Neuroimmunol · 2017 · PMC5485168 · PMID 28706565

Europe PMC DOI

hedged sentence

0.0682

closest p · 1.4× alpha

0.0682

boldest claim

The sentences

borderline significantP = 0.0682so close (0.05 < p ≤ 0.1)

corticosteroid use, the difference between pre‐ and post‐GA treatment in GdE lesions yielded a borderline significant result ( P = 0.0682).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.